Assura Group Limited
18 May 2007
Press release
07.00 18 May 2007
ASSURA GROUP LIMITED ('ASSURA')
AGM STATEMENT
Richard Burrell, Chief Executive Officer of Assura, the independent primary
health care provider organisation, will make the following statement at Assura's
Annual General Meeting at 2.00pm today.
'I am pleased to report that we are performing in line with our expectations for
the first half of the year.
The property division is continuing to work towards its target of £580m of
capital committed by the end of 2007 and £750m by the end of 2009.
The pharmacy division now has 12 pharmacies trading and is on target to have 20
opened by the end of 2007 and at least 30 by the end of 2008.
The medical division is beginning to provide services to patients through its
joint venture Limited Liability Partnerships with GPs in its six projects. A
Minor Surgery service has commenced in Bath and North East Somerset and 'willing
provider' status has been granted in Liverpool and Macclesfield for the
provision of Dermatology and Urology services respectively in these localities.
It is anticipated the provision of these services will commence during the
summer. Heads of Terms have now been signed for a further two joint ventures and
we are well on track to signing up GP practices covering 1.5 million patients by
the end of this calendar year.
Subject to shareholder approval being granted at today's AGM to change the
Group's year end to 31 March, we will be publishing final figures for the 15
months to 31 March 2008 and interim figures for the periods to 30 June 2007 and
30 September 2007. We will also make a trading statement in respect of the
period to 31 December 2007. A 31 March year end is considered more appropriate
given that the NHS and most organisations linked to the NHS, including our
medical joint venture partners, adopt a March year end.
On 4 May 2007 the final dividend of 4p per ordinary share in respect of the year
ended 31 December 2006 was paid to shareholders on the register on 10 April
2007, making a total of 6p per ordinary share for the year. We intend to
maintain our progressive dividend policy and intend to pay interim dividends in
respect of the periods ending 30 June 2007 and 30 September 2007 and a final
dividend in respect of the 15 month period ending 31 March 2008.'
- e n d s -
For further information, please contact:
Richard Burrell / Louise Bathersby Tony Langham/Charlotte Edgar
Assura Group Limited Lansons Communications
01244 893681 / 020 7107 3800 020 7294 3617 / 020 7294 3622
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.